UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 8,378 Shares of Trupanion, Inc. (NASDAQ:TRUP)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 9.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 78,065 shares of the financial services provider’s stock after selling 8,378 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Trupanion were worth $3,277,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of TRUP. Quest Partners LLC bought a new position in Trupanion in the 3rd quarter worth about $37,000. GAMMA Investing LLC raised its stake in shares of Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 596 shares in the last quarter. Headlands Technologies LLC purchased a new stake in shares of Trupanion in the second quarter valued at approximately $162,000. Entropy Technologies LP bought a new position in Trupanion in the third quarter worth approximately $202,000. Finally, Mutual of America Capital Management LLC purchased a new position in Trupanion during the 3rd quarter worth $210,000.

Trupanion Stock Down 1.3 %

Shares of TRUP opened at $52.73 on Friday. The firm has a market cap of $2.23 billion, a P/E ratio of -164.78 and a beta of 1.60. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The stock’s 50 day moving average is $52.13 and its two-hundred day moving average is $41.74. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same period in the previous year, the business earned ($0.10) EPS. Trupanion’s quarterly revenue was up 14.6% on a year-over-year basis. Analysts predict that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Insider Buying and Selling at Trupanion

In other Trupanion news, EVP Steve Weinrauch sold 11,916 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $53.00, for a total transaction of $631,548.00. Following the completion of the transaction, the executive vice president now owns 48,978 shares of the company’s stock, valued at $2,595,834. This trade represents a 19.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Murray B. Low sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the sale, the director now directly owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,405 shares of company stock worth $1,512,482 in the last three months. 5.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on TRUP shares. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Northland Securities raised their target price on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Piper Sandler upped their price target on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Finally, Stifel Nicolaus lifted their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and a consensus target price of $44.67.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.